We've found
184,457
clinical trials
We've found
184,457
clinical trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
CardiAMP™ Heart Failure Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
CardiAMP™ Heart Failure Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Clinical Trial
Updated: 12/31/1969
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Malignancies Clinical Trial
Updated: 12/31/1969
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Malignancies Clinical Trial
Updated: 12/31/1969
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Malignancies Clinical Trial
Updated: 12/31/1969
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Healthy Volunteers Clinical Trial
Updated: 12/31/1969
Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Knee Osteoarthritis Clinical Trial
Updated: 4/30/2018
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty
Status: Enrolling
Updated: 4/30/2018
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oropharynx Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oropharynx Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Short-term Perfusion Angiography Pilot Study (SPA)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Premature Infants Clinical Trial
Updated: 12/31/1969
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Asymptomatic Microscopic Hematuria Clinical Trial
Updated: 10/11/2017
Vaginal Estrogen for Asymptomatic Microscopic Hematuria
Status: Enrolling,
Phase
IV
Updated: 10/11/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Urothelial Cancer Clinical Trial
Updated: 12/31/1969
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Anterior Cruciate Ligament Reconstruction Clinical Trial
Updated: 12/31/1969
Pediatric ACL: Understanding Treatment Options
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Anterior Cruciate Ligament Reconstruction Clinical Trial
Updated: 12/31/1969
Pediatric ACL: Understanding Treatment Options
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small-Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
